Showing results (741-750 of 773) with videos related to

Sort By:
Pageof 78
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 18, 2013
The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicityValeriy G Ostapchenko, Flavio H Beraldo, Amro H Mohammad, et al.
Carbohydrate Polymers|October 21, 2025
Lemon gum blankets esophageal mucosa and promotes therapeutic effects in experimental models of gastroesophageal reflux disease: Grasps for prevention and treatmentLuiz F S L Teixeira, Katriane C Silva, Fábio O S Ribeiro, et al.
Parasitology Research|September 28, 2023
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasisMarcelo M Jesus, Daniela P Lage, Danniele L Vale, et al.
Immunobiology|June 6, 2019
A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical proteinDaniela P Lage, Amanda S Machado, Fernanda F Ramos, et al.
Molecular Immunology|December 31, 2018
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infectionPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Parasitology|September 11, 2018
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infectionGerusa B Carvalho, Lourena E Costa, Daniela P Lage, et al.
Mbio|April 27, 2017
<i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionVivian V Costa, Juliana L Del Sarto, Rebeca F Rocha, et al.
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against <i>Leishmania infantum</i> infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Parasitology|November 28, 2024
Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Fabiana A G Maia, et al.
Pageof 78